Treatment of Antibody-Mediated Rejection (ABMR) With CarBel
Clinical trial NCT06918990 · RECRUITING
Trial details
- NCT number
- NCT06918990
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-27
- Primary completion
- 2027-06-30
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.